• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Acronym List

Table of Contents: Managing the Risks From Medical Product Use: Creating a Risk Management Framework

Previous Section : Bibliography

 

AAO American Academy of Ophtholomology
AAO American Academy of Ophtholomology
AARP American Association of Retired Persons
AANN American Association of Neurosciences Nurses
AANS American Association of Neurological Surgeons
AAWG Aggregate Analysis Working Group
ACG American College of Gastroenterology
ADE Adverse Drug Event
ADR Adverse Drug Reaction
AERS Adverse Event Reporting System
AHCPR Agency for Health Care Policy and Research
AIDS Acquired Immune Deficiency Syndrome
AMS Aseptic Meningitis Syndrome
ANDA Abbreviated New Drug Application
APhA American Pharmaceutical Association
ASGE American Society for Gastrointestinal Endoscopy
BCPT Breast Cancer Prevention Trial
BPAC Blood Products Advisory Committee
BSE Bovine Spongiform Encephalopathy
CBER Center for Biologics Evaluation and Research
CDC Centers for Disease Control and Prevention
CDER Center for Drug Evaluation and Research
CDRH Center for Devices and Radiological Health
CEF Chick Embryo Fibroblast
CERTS Centers for Education and Research on Therapeutics
CGMP Current Good Manufacturing Practices
CIOMS Council for International Organizations of Medical Sciences
CJD Creutzfeldt-Jakob Disease
CNS Congress of Neurological Surgeons
CSF Cerebrospinal Fluid
CV Cardiovascular
DAVDP Division of Anti-Viral Drug Products
DIA Drug Information Association
DOD Department of Defense
DSMB Data Safety Monitoring Board
DTC Direct-to-Consumer
EIND Electronic Investigational New Drug Aplication
EMEA European Medicines Evaluation Agency
ENL Erythema Nodosum Leprosum
ESTRI Electronic Standards for the Transfer of Regulatory Information and Data
EU European Union
EWG Expert Working Group
FAO Food and Agriculture Organization of the United Nations
FD&C Federal Food, Drug, and Cosmetic Act
FOI Freedom of Information
GAO General Accounting Office
GHC Group Health Cooperative
GHTF Global Harmonization Task Force
GI Gastrointestinal
GMP Good Manufacturing Practices
GPRD General Practice Research Database
GRP Good Review Practices
HCFA Health Care Financing Administration
HGH Human Growth Hormone
HIV Human Immunodeficiency Virus
HMO Health Maintenance Organization
HRSA Health Resources and Services Administration
IAVG Interagency Vaccine Group
ICH International Conference on Harmonisation
IDE Investigational Device Exemption
IGIV Immune Globulin Intravenous
IHS Indian Health Service
IND Investigational New Drug
ISMP Institute for Safe Medication Practices
ISO International Standards Organization
JAMA Journal of the American Medical Association
JCAHO Joint Commission on Accreditation of Health Care Organizations
MAPP Manual of Policies and Procedures
MAUDE Manufacturer and User Device Experience
MDR Medical Device Reporting
MEDDRA Medical Dictionary for Drug Regulatory Affairs
MERP Medication Error Reporting and Prevention
MMR Measles, Mumps and Rubella Vaccine
MMWR Morbidity and Mortality Weekly Report
MRA Mutual Recognition Agreement
MSSO Maintenance and Support Services Organization
NACDS National Association of Chain Drug Stores
NASPE North American Society for Pacing and Electrophysiology
NCC MERP National Coordinating Council for Medication Error Reporting and Prevention
NCHS National Center for Health Statistics
NCI National Cancer Institute
NCL National Consumers League
NCPIE National Council on Patient Information and Education
NDA New Drug Application
NHLBI National Heart, Lung, and Blood Institute
NIAID National Institute of Allergy and Infectious Diseases
NIH National Institutes of Health
NIS National Inpatient Sample
NME New Molecular Entity
NNMC National Naval Medical Center
NPA National Prescription Audit
NSAID Nonsteroidal Anti-Inflammatory Drug
NSAPB National Surgical Adjuvant Breast and Bowel Project
NTDI National Disease and Therapeutic Index
OA Osteoarthritis
OBRR Office of Blood Research and Review
ODAC Oncologic Drugs Advisory Committee
ODE Office of Drug Evaluation
OEA Office of External Affairs
OHA Office of Health Affairs
OPDRA Office of Post-Marketing Drug Risk Assessment
OSB Office of Surveillance and Biometrics
OSHI Office of Special Health Issues
OTC Over the Counter
PDUFA Prescription Drug User Fee Act
PERI PhRMA Education and Research Institute
PHA Public Health Advisory
PhRMA Pharmaceutical Research and Manufacturers of America
PHS Public Health Service
PMA Premarket Approval
PSC Postmarket Strategies Committee
PSUR Periodic Safety Update Reports
QA Quality Assurance
Q&A Question and Answer
QC Quality Control
RA Rheumatoid Arthritis
RSNA Radiological Society of North America
SAMHSA Substance Abuse and Mental Health Services Administration
SCVIR Society for Cardiovascular Interventional Radiology
SMDA Safe Medical Devices Act
SOPP Manual of Standard Operating Procedures and Policies
SRS Spontaneous Reporting System
SSED Summary of Safety and Effectiveness Data
STAMP Systematic Technology Assessment of Medical Products
STEPS System for Thalidomide Education and Prescribing Safety
TSE Transmissible Spongiform Encephalopathies
TSEAC Transmissible Spongiform Encephalopathies Advisory Committee
TTTC Take Time To Care
USP U.S. Pharmacopeia
USUHS Uniformed Services University of the Health Sciences
VAERS Vaccine Adverse Event Reporting System
VSD Vaccine Safety Datalink
WHO World Health Organization

Next Section : Appendices